Figure 3
Scatter Plot of Incremental Costs and QALYs for PMO T −3.0/2 Fracture Cohort: Teriparatide vs. Bisphosphonate Treatment.
Figure 3 | BMC Musculoskeletal Disorders
Scatter Plot of Incremental Costs and QALYs for PMO T −3.0/2 Fracture Cohort: Teriparatide vs. Bisphosphonate Treatment.